#nhs-drug-pricing

[ follow ]
#pharmaceutical-investment #government-policy #vaccine-manufacturing #uk-life-sciences
#pharmaceutical-investment
more#pharmaceutical-investment
UK politics
fromwww.theguardian.com
2 weeks ago

Who benefits if NHS drug prices soar? Donald Trump and big pharma. Just one more way he's menacing Britain | Polly Toynbee

US tariff threats and pricing demands are pushing UK pharmaceutical investment away, undermining British life sciences and straining NHS drug-price negotiations.
London
fromwww.theguardian.com
3 weeks ago

UK government must heed warns over big pharma investment

High NHS clawbacks and relatively low UK medicine spending deter major pharmaceutical investment despite strong research infrastructure.
Medicine
fromwww.theguardian.com
1 month ago

Wes Streeting's row with pharma firms grows as talks end on NHS drug pricing

Government and pharmaceutical companies remain deadlocked over VPAG NHS drug pricing, so the existing high clawback rate will continue, risking reduced UK medicine launches.
[ Load more ]